Login / Signup

Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes.

Myeong-Kyun ShinSusan PayneAndrea BilgerKristina A MatkowskyjEvie CarchmanDominique S MeyerMohamed Bentires-AljDustin A DemingPaul F Lambert
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)
These data demonstrate that activating mutations in Pik3ca drive anal carcinogenesis together with HPV16 oncogenes, and that the PI3K/mTOR pathway is a relevant target for therapeutic intervention.
Keyphrases
  • high grade
  • signaling pathway
  • randomized controlled trial
  • protein kinase
  • electronic health record
  • cell proliferation
  • big data
  • cervical cancer screening
  • data analysis